Business Standard

Medicamen Biotech standalone net profit declines 30.00% in the September 2015 quarter

Image

Capital Market

Sales decline 34.31% to Rs 17.94 crore

Net profit of Medicamen Biotech declined 30.00% to Rs 0.35 crore in the quarter ended September 2015 as against Rs 0.50 crore during the previous quarter ended September 2014. Sales declined 34.31% to Rs 17.94 crore in the quarter ended September 2015 as against Rs 27.31 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales17.9427.31 -34 OPM %6.806.19 -PBDT0.791.14 -31 PBT0.320.61 -48 NP0.350.50 -30

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 14 2015 | 6:14 PM IST

Explore News